This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.


  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Jun. 21, 2012

   Home   Mission/Vision    Membership    Corporate Membership    CME/CEU    JMCM    Contact Us

Register Today for a Webinar on "Improving Outcomes with Virtual Health Assistants."

Click Here to view the Journal of Managed Care Medicine

Online CME/CEU Programs
Multiple Myeloma: An Update on Diagnostic and Treatment Strategies

Advanced Treatment of Osteoporosis in Postmenopausal Women

Decreasing the Cost Burden of Fibromyalgia with Early Diagnosis and Management


Announcing the NAMCP Medical Directors Lung Cancer Resource Center. Click here to visit the website.

Be sure to check out the study results of Verinata's Non-Invasive Prenatal Technology. Click here to view the press release.

Click here to check out the "Latest in Clinical Nutrition" DVD available for purchase now!

Fall Managed Care Forum
November 8-9
Bellagio Hotel

 



 Genomics

Robust octogenarians' genes seen holding secrets to aging
Bloomberg    Share    Share on FacebookTwitterShare on LinkedinE-mail article
James Markam is alive and well, despite losing four siblings to disease. Scientists are looking at Markam's genetics to see if there's something protecting him from illnesses that affect others his age. Markam, 83, is one of more than 1,300 individuals identified as having what one researcher called "Teflon-coated" genes. More

What is the Health Economic Impact of a Non-Invasive Prenatal Test?

Learn About Bridgehead International’s report, authored by Susan Garfield, on the clinical and economic utility of this test in this quarter’s JMCM, entitled “Clinical and Cost Consequences of Incorporating a Novel Non-Invasive Prenatal Test into the Diagnostic Pathway for Fetal Trisomies.


Researchers identify possible Alzheimer's, diabetes gene link
BBC News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
It has been known for some time that people with diabetes have a much higher risk of developing Alzheimer's, but not why this is so. Now researchers writing in Genetics say a study of worms has indicated a known Alzheimer's gene also plays a role in the way insulin is processed. More

Study: Opiates' side effects rooted in patients' genetics
Medical Xpress    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Genetics play a significant role in determining which patients will suffer the most from the disturbing side effects of opiates, commonly prescribed painkillers for severe to moderate pain, according to a new Stanford University study, which pinpoints nausea, slowed breathing and potential for addiction as heritable traits. More

 Biotech/Diagnostics/Personalized Medicine


AMA bucks US task force on mammography screenings
MedPage Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The American Medical Association's House of Delegates has come out in support of routine screening mammography for women starting at age 40. The new policy is in direct conflict with the controversial 2009 recommendation of the United States Preventive Services Task Force that routine screening mammography for breast cancer was unnecessary in women younger than 50. More

What is 'histrionic personality disorder?'
USA Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Few outside the psychiatric community knew about "histrionic personality disorder" until it was reported that attorneys for former Penn State assistant football coach Jerry Sandusky would bring it up in his defense on child sex abuse charges. The condition is defined in the American Psychiatric Association's diagnostic manual as "a pervasive pattern of excessive emotionality and attention seeking." More

Are targeted cancer therapies doomed to fail?
MedPage Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Resistance to targeted cancer therapies may be almost inevitable, at least if they are used alone, two groups of researchers reported online in Nature. Mathematical modeling, based on genetic testing of colorectal cancer patients, suggests that resistance already exists even before targeted therapy begins, researchers said. More


Nursing@
Georgetown


Nursing@Georgetown is a Master’s in Nursing program delivered online by Georgetown University’s renowned School of Nursing & Health Studies.
MORE
Our activities touch many lives
AstraZeneca is a global, innovation-driven, integrated biopharmaceutical company. We discover, develop, manufacture and market prescription medicines for cancer, cardiovascular, gastrointestinal and infection. MORE


 Regenerative Medicine


Stem cells move into prime time
Science Magazine    Share    Share on FacebookTwitterShare on LinkedinE-mail article
For more than a decade, stem cell therapies have been touted as offering hope for those suffering from genetic and degenerative diseases. The promise inched toward reality recently with announcements that two groups are moving forward with human clinical research, one focusing on a rare genetic neurological disease and the other for loss of vision in the elderly. More

Decades-old cancer drug points to new ALS treatments
Laboratory Equipment    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A long-used anti-cancer drug could be a starting point to develop new treatments for the incurable nerve disease known as Lou Gehrig's disease or amyotrophic lateral sclerosis, scientists report. Their research showing how the drug prevents clumping of an enzyme linked to ALS appears in the Journal of the American Chemical Society. More

 Emerging Medical Technologies


Physicians could see more medical devices going mobile
American Medical News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
If all goes as the wireless health industry plans, it can start introducing far more products that allow physicians to monitor patients with no wires attached. The Federal Communications Commission announced that wireless monitoring devices will be allowed to transmit data by spectrum bands previously reserved for use by the aerospace industry for flight testing. More

Top 11 emerging chronic disease technologies to watch
Healthcare Finance News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Health policy institute NEHI has identified 11 emerging technologies that have the potential to improve care and lower costs for chronic disease patients, especially those in at-risk populations. More

 Managed Healthcare News


Trauma in the ER: Who covers the uninsured?
Los Angeles Times    Share    Share on FacebookTwitterShare on LinkedinE-mail article
As happens daily in emergency rooms nationwide, uninsured patients receive medical care guaranteed by a generation-old federal mandate that requires hospitals to care for all in need, regardless of ability to pay. For 26 years, the Emergency Medical Treatment and Active Labor Act, or EMTALA, has been a bedrock principle of American healthcare. More

Big companies offering more on-site healthcare for employees
The Washington Post    Share    Share on FacebookTwitterShare on LinkedinE-mail article
On-site workplace clinics used to be primarily focused on patching up people who got injured on the job. Now, some big employers are beefing up their clinic offerings further with a host of add-ons, including physical therapy, dental and vision exams, mental health counseling and even acupuncture and massage. More

 FDA: New Treatments and Technology


Supreme Court rejects labor view on sales-rep overtime
Forbes    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The Supreme Court has rejected the Labor Department's interpretation of federal law and ruled that thousands of SmithKline Beecham sales representatives were exempt from overtime rules. The decision is a rebuke to the Obama administration, which argued that some 90,000 drug reps and so-called detailers across the pharmaceutical industry should be covered under the 1938 law designed to protect workers from exploitation and excessive hours. More

Roche in deal to treat root cause of autism
Reuters    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Swiss drugmaker Roche plans to work with firm Seaside Therapeutics to develop treatments for autism spectrum disorders and fragile X syndrome that differ fundamentally from other methods by targeting their molecular basis. Autism spectrum disorders include Asperger's syndrome and autism, with symptoms that range from social awkwardness and narrow interests to severe communication and intellectual disabilities. More

FAST FACTS
"The majority — 90 percent — of patients with adult-onset ALS have no family history of it, according to the ALS Association. It is hereditary in only a small number of families. Since the vast majority of patients do not have the hereditary type, ALS diagnosis is not determined by a genetic test."
 
Genomics Biotech and Emerging Medical Technologies Institute eBrief
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Christine Kraly, Content Editor, 469.420.2685   
Contribute news

This edition of the Genomics Biotech and Emerging Medical Technologies Institute eBrief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
June 14, 2012
June 7, 2012
May 31, 2012
May 24, 2012



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063